Osteoporosis Flashcards

1
Q

Typical demographic

A

Older females

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Major risk factors for osteoporosis

A

steroid use
rheumatoid arthritis
alcohol excess
Family Hx
low body mass index
current smoking

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Other (non major) risk factors

A
  • sedentary lifestyle
  • premature menopause
  • Caucasians and Asians
  • endocrine disorders
  • multiple myeloma, lymphoma
  • GI disorders: IBD, coeliac, gastrectomy, liver disease
  • CKD
  • osteogenesis imperfecta
  • homocystinuria
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Give examples of medications which may worsen osteoporosis

A

SSRIs
antiepileptics
proton pump inhibitors
glitazones
long term heparin therapy
aromatase inhibitors e.g. anastrozole

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What investigations must be completed after a patient develops a fragility fracture?

A

Bloods: FBC, CRP, calcium, albumin, creatinine, phosphate, ALP and liver transaminases, TFTs

Bone densitometry ( DXA)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What is the T score used in DEXA scanning?

A

T score: based on bone mass of young reference population
T score of -1.0 means bone mass of one standard deviation below that of young reference population

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is Z score in DEXA scanning?

A

Z score is adjusted for age, gender and ethnic factors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Explain the cut offs for the T score and how someone maybe diagnosed with osteoporosis

A

> -1.0 = normal
-1.0 to -2.5 = osteopaenia
< -2.5 = osteoporosis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

When is the risk of osteoporosis thought to rise significantly in patients taking steroids?

A

taking the equivalent of prednisolone 7.5mg a day for 3 or more months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

If a patient is on steroids and is >65years with a history of previous fragility fracture, should they receive bone protection

A

Yes

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

If a patient on steroids is <65 with no history of fragility fracture, how do we decide if they require bone protection?

A

DEXA scan

T score:
>0 = Reassure
Between 0 and -1.5 = Repeat bone density scan in 1-3 years
< -1.5 = Offer bone protection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

First line agent

A

Alendronate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

If patients cannot take alendronate, what should be used instead?

A

Risedronate or etidronate

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Other osteoporosis treatments

A

strontium ranelate
raloxifene
denosumab

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Raloxifene mechanism of action

A

selective oestrogen receptor modulator (SERM)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Raloxifene side effects

A

may worsen menopausal symptoms
increased risk of thromboembolic events
may decrease risk of breast cancer

17
Q

Adverse effects of strontium ranelate

A

increased risk of cardiovascular events and
thromboembolic events
may cause serious skin reactions such as Stevens Johnson syndrome

18
Q

Mechanism of action of strontium

A

increases deposition of new bone by osteoblasts
(promotes pre-osteoblasts to become osteoblasts)
reduces the resorption of bone by inhibiting osteoclasts

19
Q

Mechanism of denosumab

A

human monoclonal antibody that inhibits RANK ligand

in turn inhibits the maturation of osteoclasts

20
Q

how is denosumab given

A

subcutaneous injection every 6 months

21
Q

What is teriparatide and what is its mechanism of action

A

recombinant form of parathyroid hormone

22
Q

HRT has been shown to reduce the incidence of vertebral fracture and non-vertebral fractures. TRUE/FALSE?

A

TRUE
- Due to increased rates of cardiovascular disease and breast cancer it is no longer recommended for primary or secondary prevention of osteoporosis

23
Q
A